|
L-theanine is Effective in Lessening Positive Symptoms, and improving Sleep Quality in patients with schizophrenia
|
|
438
|
95394
|
August 1, 2025
|
|
Please Read - Intro to Schizophrenia News Discussions
|
|
5
|
20254
|
February 9, 2017
|
|
Advanced techniques separate genetic risk of schizophrenia and bipolar
|
|
0
|
11
|
February 19, 2026
|
|
Alcohol use disorder and IQ: Does social context matter? - National Elf Service
|
|
0
|
10
|
February 18, 2026
|
|
Science, serendipity and a new era for schizophrenia treatment | Psyche Ideas
|
|
1
|
33
|
February 18, 2026
|
|
Cognitive profiles in older adults with psychotic disorders: Results from
|
|
0
|
29
|
February 10, 2026
|
|
The effect of weight loss on brain age in schizophrenia spectrum disorders
|
|
0
|
26
|
February 10, 2026
|
|
Ketogenic Diet for Schizophrenia
|
|
1
|
78
|
February 8, 2026
|
|
When CBT doesn't work for OCD: could mindfulness help? - National Elf Service
|
|
0
|
10
|
February 5, 2026
|
|
Millennials, Gen Z Suffering Increased Rates Of Psychosis, Schizophrenia
|
|
3
|
60
|
February 3, 2026
|
|
Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
|
|
2
|
133
|
February 3, 2026
|
|
🧠Schizophrenia: the unexpected role of the cerebellum
|
|
0
|
34
|
February 3, 2026
|
|
Comparison of the effects of aerobic exercise and computer-based cognitive stimulation in patients with schizophrenia - A randomized controlled trial
|
|
0
|
12
|
February 2, 2026
|
|
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics
|
|
0
|
50
|
January 31, 2026
|
|
Do antipsychotics slow your thinking? Cognitive effects on working memory
|
|
4
|
88
|
January 28, 2026
|
|
Study reveals struggles precede psychosis risk by years
|
|
0
|
34
|
January 27, 2026
|
|
Predicting negative symptoms: a novel scale for assessing anticipatory
|
|
0
|
26
|
January 22, 2026
|
|
Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms
|
|
0
|
25
|
January 22, 2026
|
|
Medication impact on non-core ADHD symptoms and harm prevention
|
|
0
|
18
|
January 21, 2026
|
|
Brilaroxazine needs another Phase 3 trial
|
|
0
|
54
|
January 20, 2026
|
|
A symptom network approach to schizophrenia in the CATIE study: processing
|
|
0
|
18
|
January 20, 2026
|
|
Mental health admissions to medical wards: 65% increase in a decade for young
|
|
0
|
23
|
January 20, 2026
|
|
Randomized double-blind inpatient study of a gluten-free diet for negative
|
|
0
|
24
|
January 17, 2026
|
|
The relationship between schizophrenia polygenic scores, blood-based proteins and psychosis diagnosis in the UK Biobank
|
|
0
|
20
|
January 14, 2026
|
|
Psychosis patients ‘living in metaphor’ - new study radically shifts ideas about delusions
|
|
1
|
65
|
January 13, 2026
|
|
Consensus reached on the meaning of relapse in schizophrenia, or is it? -
|
|
0
|
19
|
January 13, 2026
|
|
Anticholinergic Burden and Its Effect on Cognition in Psychosis |
|
|
0
|
22
|
January 12, 2026
|
|
Hemodialysis dramatically alleviates treatment-refractory psychosis in a
|
|
0
|
36
|
January 6, 2026
|
|
Vaccine protection against COVID-19-related mortality in patients with
|
|
0
|
33
|
January 5, 2026
|
|
Patent Issued for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar disorder
|
|
5
|
155
|
January 3, 2026
|